MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.oraloncology.2026.107849

Медицинская библиотека · Oral oncology · 2026

Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort study.

Søby Sebastian, Mortensen Danny, Gothelf Anita, Gyldenkerne Niels, Maare Christian, Lonkvist Camilla K, Andersen Maria, Kjeldsen Rasmus, Toustrup Kasper, Tramm Trine, Eriksen Jesper Grau

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

PD-1 inhibition has become an established treatment option for recurrent/metastatic head and neck squamous cell carcinoma (rmHNSCC). However, there is a clear need for improved prognostic tools. This study aimed to identify immune-related tissue biomarkers associated with overall survival (OS) or progression-free survival (PFS) in patients treated with PD-1 inhibition. This national real-world phase IV multicenter retrospective cohort study included Danish patients treated between 2017 and 2023. Pre-treatment biopsies were collected for immunohistochemical analyses. All patients were PD-L1 positive with histologically confirmed rmHNSCC treated with pembrolizumab or nivolumab monotherapy. Biomarker expression was assessed for CD4, CD8, FOXP3, CD20, CD66b, CD68, STING, cGAS, and tumor-infiltrating lymphocytes (TILs), using the median expression as the cut-off value. Formalin-fixed, paraffin-embedded tumor tissue was obtained from 263 eligible patients. Concurrent above median levels of FOXP3 and CD68 were associated with a lower risk of progression (HRPFS: 0.47 [95 % CI: 0.33-0.67]). This interaction appeared to be driven by p16+ oropharyngeal cancers (OPC), where patients with concurrent above median levels of FOXP3 and CD68 showed a median 2-year PFS of 68 % [95 % CI: 42-86] in contrast to those with one or none of the two markers above the median level with a 2-year PFS of 3 % [95 % CI: 0-12] (p < 0.001). In this real-world cohort, a subgroup with a promising prognosis was identified. This subgroup was characterized by p16+ OPC along with concurrent above median levels of FOXP3 and CD68. PD-L1 alone showed no significant association with outcomes.

Для цитирования: Søby Sebastian, Mortensen Danny, Gothelf Anita, Gyldenkerne Niels, Maare Christian, Lonkvist Camilla K, Andersen Maria, Kjeldsen Rasmus, Toustrup Kasper, Tramm Trine, Eriksen Jesper Grau. Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort study.. Oral oncology. 2026. DOI: 10.1016/j.oraloncology.2026.107849.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.